CellaVision AB (CLVSF)
CellaVision Market Cap: 412.63M for Jan. 21, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Vivesto AB | 1.030M |
| BioInvent International AB | 216.40M |
| Hansa Biopharma AB | 290.20M |
| BioArctic AB | 3.128B |
| Camurus AB | 4.232B |
Market Cap Related Metrics
| PE Ratio | 27.74 |
| PS Ratio | 5.589 |
| PEG Ratio | 6.014 |
| Price to Book Value | 4.558 |
| Price to Free Cash Flow | 32.74 |
| Price | 17.30 |
| Earnings Yield | 3.60% |
| PEGY Ratio | 4.525 |
| Operating PE Ratio | 21.19 |
| Normalized PE Ratio | 27.75 |